Skip to main content

Table 2 Eligibility criteria according to PICOS

From: Comprehensive preclinical studies on the bioactivity of Orbignya phalerata Mart. (Babassu) and its derived products: a systematic review

 

In vivo

In vitro

P

Experimental strains of any sex, age, and weight

Tumor and non-tumor cell lines and/or microorganism strains, and/or chemical assays

I

Oral or gavage offering of crude or processed babassu components or isolated extracted compounds

Assays with crude or processed babassu components or isolated extracted compounds

C

Positive, negative, and/or parallel control

Positive, negative, and/or parallel control

O

Favorable or unfavorable biological effects, local or systemic, acute or chronic

Favorable or unfavorable biological effects for/against pathogenic or non-pathogenic microorganisms, cell lines, or chemical reactions

S

In vivo experimental studies

In vitro experimental studies